Test Price
2,800 AED✅ Home Collection Available
MYO16-Related Autism Spectrum Disorder Genetic Test in Dubai, UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity for MYO16 variants via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic counsellor.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price: 2,800 AED — Comprehensive MYO16 targeted NGS analysis with variant-specific reporting.
Test Overview & Methodology
The MYO16 gene encodes myosin XVI, a protein essential for neuronal development and synaptic function. Pathogenic variants in MYO16 have been strongly associated with autism spectrum disorder (ASD). This targeted next-generation sequencing (NGS) test detects single nucleotide variants, small insertions, and deletions across all coding exons and flanking intronic regions of MYO16 with 99.9% sensitivity and specificity. Early molecular confirmation enables timely behavioral interventions, educational planning, and informed family counselling.
Comparative Test Selection
| Feature | Our Test (MYO16-Targeted NGS) | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | 99.9% sensitivity & specificity for MYO16 variants | Broad screening; MYO16 may need confirmatory testing |
| Method | Next-Generation Sequencing with variant‑specific bioinformatics | Whole exome capture + general analysis |
| Speed | Results in 21–28 business days | Typically 6–8 weeks; often requires Sanger confirmation |
| Cost | 2,800 AED (targeted, clinically actionable report) | 4,500–7,000 AED (broader but less focused) |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I emphasize that this test is a powerful diagnostic adjunct but must be interpreted alongside a comprehensive clinical assessment inclusive of developmental history, family pedigree, and behavioural observations. A positive result provides clarity for targeted intervention; a negative result does not exclude other genetic or environmental contributors to autism spectrum disorder. Patients and families should maintain all current therapies and consult their treating neurologist or psychiatrist before making any medication changes.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Safety Advisory
Do not discontinue prescribed medication without consulting your doctor.
A genetic test result — whether positive or negative — does not replace the medical judgment of your treating physician. Continue all behavioural, educational, and pharmacological therapies as directed.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Acute bleeding disorder, severe needle phobia preventing safe venipuncture, inability to provide informed consent.
- Exclusion: DNA from FTA card or extracted DNA sample that does not meet quality thresholds for NGS.
- Emergency Red Flag: If the patient demonstrates sudden self-harm, aggression, or acute psychosis, seek emergency psychiatric care immediately.
Patient FAQ & Clinical Guidance
1. What does a positive MYO16 result mean for my child’s future?
A positive MYO16 mutation indicates a strong genetic link to autism spectrum disorder, guiding early behavioral and educational interventions. Further family testing and genetic counselling are recommended to assess recurrence risk and inform family planning.
2. How should I prepare myself or my family member for the test?
No fasting is required. A whole blood sample (EDTA tube), a single dried blood spot on an FTA card, or previously extracted high-quality DNA is accepted. A pre-test genetic counselling session and pedigree chart are recommended to ensure informed consent and optimal result interpretation.
3. Will my insurance cover this genetic test?
Coverage varies by policy. Our team directly verifies benefits and handles pre‑approval via WhatsApp at +971 54 548 8731 before your appointment. We also offer a transparent self-pay rate of 2,800 AED for uninsured patients.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under the regulatory oversight of the Dubai Health Authority (DHA) and adheres strictly to UAE federal data protection and health information governance frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the lawful collection, processing, and storage of personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — ensuring secure handling of electronic health records and telemedicine communications.
- Federal Decree-Law No. 4 of 2016 on Medical Liability — establishing standards for clinical testing safety, informed consent, and patient rights.
All genetic data is encrypted, access-controlled, and retained only for the duration required by law. Results are shared exclusively with the ordering physician and the patient or legal guardian.
Clinical & Logistical Metadata
| Test Name | MYO16-Related Autism Spectrum Disorder Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Business Days |
| Sample Type / Matrix | Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) with Variant-Specific Bioinformatics Analysis |
| ICD-10-CM Code | F84.0 |
| LOINC Code | 91860-6 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians